access intranet after hours circle-arrow apply blog caret circle arrow close closer look community outreach community outreach contact contact us down arrow facebook lock solid find a provider find a clinical trial find a provider find a researcher find faculty find-a-service how to apply join leadership left arrow locations logo make a gift map location maximize minimize my chart my chart notification hp notification lp next chevron right nxt prev pay your bill play previous quality and safety refer a patient request a speaker request appointment request an appointment residents corner rss search search jobs Asset 65 submit a story idea symptom checker Arrow Circle Up twitter youtube Dino Logo External Link University Logo Color University Logo Solid Health Logo Solid Arrow Right Circle Book Calendar Date Calendar Search Date Diploma Certificate Dollar Circle Donate Envelope Graduation Cap Map Pin Map Search Phone Pills Podcast
Hollings Celebrates 30 Years of BMT

Hematology & Oncology

As the largest academic cancer center in South Carolina, the MUSC Hollings Cancer Center (HCC) is the state's only National Cancer Institute (NCI)-designated cancer center and one of only 69 NCI centers in the U.S. As an integral component of the Hollings Cancer Center, the MUSC Division of Hematology & Oncology builds upon a long history of excellence in hematology and hematological malignancies, as well as solid tumor oncology and bone marrow transplant. Division faculty are leaders in the fields of cancer care and blood disorders. In the latest rankings by U.S. News & World Report, MUSC Health's Hematology/Oncology program ranked as one of the country's top 25 programs (#24) for the treatment of cancer.

Patient Care

The Division specializes in a wide range of malignant diseases and blood disorders and serves as a statewide referral center for solid tumor oncology, malignant and benign hematology, and bone marrow transplant. The Division's faculty is heavily engaged in numerous multidisciplinary tumor boards and clinics at the University, ensuring that clinicians are able to collaborate across disciplines on patient care and allowing many patients with malignancies to see all of their physicians in one appointment.  

Research

The Division's faculty members are equally committed to research and lead efforts in the laboratory as well as conduct clinical trials. Our comprehensive treatment protocols include an ever-expanding clinical trials portfolio offering studies for most types of cancer and blood disorders. As an NCI-Designated Cancer Center, Hollings offers clinical trials and therapies not available elsewhere in South Carolina.

Education

The Division’s fellowship program continues to recruit top tier candidates and is the only hematology oncology training program in the state of South Carolina. The program provides each fellow extensive clinical training in outpatient, inpatient, and consultative medical oncology and benign and malignant hematology, including autologous and allogeneic stem cell transplantation. 

Related News

Dr. Rubinstein and Wrangle

New immunotherapy for lung cancer shows promise of success